Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
Guardant360® Liquid
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Guardant Health
Type:
Laboratory Developed Test
Related tests:
‹
Guardant360® CDx (54)
GuardantOMNI (10)
Guardant360 TissueNext™ (2)
Guardant360 Response™ (1)
GUARDANT SHIELD
GuardantINFINITY™
GuardantREVEAL
Lunar-2
Guardant360® CDx (54)
GuardantOMNI (10)
Guardant360 TissueNext™ (2)
Guardant360 Response™ (1)
GUARDANT SHIELD
GuardantINFINITY™
GuardantREVEAL
Lunar-2
›
Details
Evidence
News
A comprehensive liquid profiling test that evaluates 744 genes and includes TMB, MSI status, and ever-expanding epigenomic features.
Cancer:
Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer
Gene:
ALK (Anaplastic lymphoma kinase), BRAF (B-raf proto-oncogene), MSI (Microsatellite instability), TMB (Tumor Mutational Burden)
ALK (Anaplastic lymphoma kinase), BRAF (B-raf proto-oncogene), MSI (Microsatellite instability), TMB (Tumor Mutational Burden)
Method:
Next-Generation Sequencing (NGS)
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.